ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Daiichi Sankyo Initiates Pivotal Phase 3 Trial of [Fam-] DS-8201
January 15, 2019Daiichi Sankyo announced that the first patient has been dosed in DESTINY-Breast04, a global pivotal phase 3 study evaluating the safety and efficacy of [fam-] trastuzumab deruxtecan (DS-8201).... -
FDA approves first cancer drug through new oncology review pilot that enables greater development efficiency
July 19, 2018The U.S. Food and Drug Administration today approved Kisqali (ribociclib) in combination with an aromatase inhibitor for the treatment of pre/perimenopausal or postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor recepto
Pharma Sources Insight January 2025
